Online Purchasing Account You are logged on as Guest. LoginRegister a New AccountShopping cart (Empty)
United States 

Omeprazole

CYP2C19 inhibitor. H+/K+ ATPase inhibitor.
 
ENZ-CHM267-0050 50 mg 60.00 USD
 
ENZ-CHM267-0500 500 mg 250.00 USD
 
Omeprazole inhibits H+K+-ATPase (IC50 = 5.8 μM). Potent inhibitor of CYP2C19 (Ki=3.1 mM); enhances efficacy of remdesivir (10-fold). Inhibits swelling-dependent chloride channels. Raises stomach pH, which in turn improves oral bioavailability of bioactive peptides such as oxytocin. Displays broad spectrum antiviral activity.

Product Details

Formula:C17H19N3O3S
 
MW:345.4
 
CAS:73590-58-6
 
Formulation:Lyophilized.
 
Purity:≥98% (TLC)
 
Identity:Identity determined by NMR.
 
Appearance:White solid.
 
Solubility:Soluble in DMSO (30 mg/ml) or ethanol (5 mg/ml).
 
Shipping:Ambient
 
Long Term Storage:-20°C
 
Use/Stability:Stable for at least 2 years after receipt when stored unopened at -20°C
 
Regulatory Status:RUO - Research Use Only
 
ENZ-CHM267 structure
Please mouse over
ENZ-CHM267 structure

Product Toolbox

PRODUCT RESOURCES

Datasheet
MSDS
Certificate of Analysis

RELATED PRODUCTS

By target:
Cytochrome P450
ATPase
By biological activity:
Cytochrome P450 Inhibitor
ATPase Inhibitor
By catalog section:

PRODUCT SUPPORT

FAQs
Technical Service
Customer Service

Recommend this page

 
Keep in touch

©2021 Enzo Life Sciences, Inc.,